Global Cancer Technology to raise $9M through a Reg A+ offering to fund potential COVID treatment
Global Cancer Technology Inc CEO John Clark tells Proactive the privately-held biopharmaceutical…
Partnerships at Barrow Neurological Institute to Commercialize New Glioblastoma Treatment
Together with scientists from the University of California San Diego, Global Cancer Technology (GCT)…
Global Cancer Technology Signs Agreement with Barrow Neurological Institute to Commercialize
Global Cancer Technology Signs Agreement with Barrow Neurological Institute to…
A Novel Treatment Modality for COVID-19
Global Cancer Technology is Developing a Light-emitting Nanoparticle Which May…
Licenses Autophagy Modulators from Neuropore Therapies
GLOBAL CANCER TECHNOLOGY LICENSES AUTOPHAGY MODULATORS FROM NEUROPORE THERAPIES FOR
Global Cancer Technology Receives SEC Notice of Qualification for Reg A+ Tier II Registration
Company Plans to Raise $9 Million USD with Proceeds to Fund New COVID Treatment Using Nanoparticles, UV Light and…
Global Cancer Technology launches Regulation CF
Global Cancer Technology launches Regulation CF equity crowdfunding campaign.
Global Cancer Technology appoints Chief Technology Officer
Global Cancer Technology appoints UC San Diego Moores Cancer Center researcher, Dr…
Remote-Controlled Cancer Drug Delivery Platform
New paradigm for killing deep-seated tumors without harming normal tissue.